JAMA Network Home
Sign In
Editorial

Tirofiban for Branch Atheromatous Disease—End of the Line or New Opportunity?

JAMA Neurology 10.1001/jamaneurol.2026.2776

August 31, 2026 at 11:00 AM EDT

Read the full article

Corresponding Author: Dixon Yang, MD, MS, Department of Neurological Sciences, Rush University, 1725 W Harrison St, Ste 1121G, Chicago, IL 60612 (dixon_yang@rush.edu).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

https://jamanetwork.com/journals/jamaneurology/fullarticle/10.1001/jamaneurol.2026.2776?utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_term=083126

Copy to clipboard

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.

Editor's Picks